The Respiratory Syncytial Virus IgG ELISA is intended for the qualitative determination of IgG class antibodies against respiratory syncytial virus in human serum or plasma (citrate,…
The Respiratory Syncytial Virus IgG ELISA is intended for the qualitative determination of IgG class antibodies against respiratory syncytial virus in human serum or plasma (citrate, heparin).
Who Else Makes It
Registered in Zhejiang.
Record
Regulatory record for NovaLisa Respiratory Syncytial Virus IgG | Listed by | Gold Standard Diagnostics Frankfurt GmbH, Germany |
| FDA product code | MCE |
| Device type | Respiratory Syncytial Virus – Elisa |
| Device class | Class 1 |
| Regulation | 21 CFR 866.3480 |
| Establishment | Contract manufacturer, Manufacturer |
| Premarket notification | Exempt |
| Record published | 2024-08-26 |
| Record revised | 2024-09-10 (version 2) |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Single use | Yes |
| Prescription | Prescription only |
| Label carries | lot or batch number, expiry date |
| Storage | Storage environment temperature 2 to 8 °C |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.